These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8083518)

  • 1. Methods for studying antiviral functions of macrophages and mononuclear phagocytes.
    Keller F
    J Immunol Methods; 1994 Sep; 174(1-2):167-72. PubMed ID: 8083518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of mouse hepatitis virus 3 with Kupffer cells explanted from susceptible and resistant mouse strains. Antiviral activity, interleukin-1 synthesis.
    Keller F; Schmitt C; Kirn A
    FEMS Microbiol Immunol; 1988 Jul; 1(2):87-95. PubMed ID: 2856206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage antiviral activity: extrinsic versus intrinsic activity.
    Stohlman SA; Woodward JG; Frelinger JA
    Infect Immun; 1982 May; 36(2):672-7. PubMed ID: 6282756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
    Pope M; Chung SW; Mosmann T; Leibowitz JL; Gorczynski RM; Levy GA
    J Immunol; 1996 May; 156(9):3342-9. PubMed ID: 8617959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antiviral properties of endotoxin-activated rat Kupffer cells.
    Keller F; Wild MT; Kirn A
    J Leukoc Biol; 1985 Aug; 38(2):293-303. PubMed ID: 3861746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of spleen macrophages in innate and acquired immune responses against mouse hepatitis virus strain A59.
    Wijburg OL; Heemskerk MH; Boog CJ; Van Rooijen N
    Immunology; 1997 Oct; 92(2):252-8. PubMed ID: 9415034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3.
    Yang C; Chen Y; Guo G; Li H; Cao D; Xu H; Guo S; Fei L; Yan W; Ning Q; Zheng L; Wu Y
    Gut; 2013 Aug; 62(8):1204-13. PubMed ID: 22637698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of macrophage source and activation on susceptibility in an age-dependent model of murine hepatitis caused by a phlebovirus, Punta Toro.
    Latham PS; Sepelak SB
    Arch Virol; 1992; 122(1-2):175-85. PubMed ID: 1370368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication.
    Pope M; Rotstein O; Cole E; Sinclair S; Parr R; Cruz B; Fingerote R; Chung S; Gorczynski R; Fung L
    J Virol; 1995 Sep; 69(9):5252-60. PubMed ID: 7636967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of macrophage procoagulant activity in mouse hepatitis virus (MHV) infection: studies using T cell MHV-3 clones and monoclonal antibody 3D4.3.
    Chung S; Li C; Fung LS; Crow A; Gorczynski R; Cole E; Perlman S; Leibowitz J; Levy G
    Adv Exp Med Biol; 1993; 342():377-84. PubMed ID: 8209757
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice.
    Levy GA; Leibowitz JL; Edgington TS
    J Exp Med; 1981 Oct; 154(4):1150-63. PubMed ID: 6270227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mouse hepatitis virus type 3 multiplication in activated Kupffer cells.
    Pereira CA; Steffan AM; Koehren F; Kirn A
    Braz J Med Biol Res; 1985; 18(4):527-31. PubMed ID: 2425874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired immunity of A/J mice to mouse hepatitis virus 3 infection: dependence on interferon-gamma synthesis and macrophage sensitivity to interferon-gamma.
    Lucchiari MA; Martin JP; Modolell M; Pereira CA
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1317-22. PubMed ID: 1646275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to murine hepatitis virus strain 3 is dependent on production of nitric oxide.
    Pope M; Marsden PA; Cole E; Sloan S; Fung LS; Ning Q; Ding JW; Leibowitz JL; Phillips MJ; Levy GA
    J Virol; 1998 Sep; 72(9):7084-90. PubMed ID: 9696801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression.
    Yu H; Liu Y; Wang H; Wan X; Huang J; Yan W; Xi D; Luo X; Shen G; Ning Q
    Front Immunol; 2018; 9():2935. PubMed ID: 30619295
    [No Abstract]   [Full Text] [Related]  

  • 16. Inflammatory monocytes recruited to the liver within 24 hours after virus-induced inflammation resemble Kupffer cells but are functionally distinct.
    Movita D; van de Garde MD; Biesta P; Kreefft K; Haagmans B; Zuniga E; Herschke F; De Jonghe S; Janssen HL; Gama L; Boonstra A; Vanwolleghem T
    J Virol; 2015 May; 89(9):4809-17. PubMed ID: 25673700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related changes in susceptibility of mice to low-virulent mouse hepatitis virus (MHV-2-CC) infection.
    Suzuki H; Kiatipattanasakul W; Kajikawa S; Tsutsui S; Nakayama H; Goto N; Doi K
    Exp Anim; 1997 Jul; 46(3):211-8. PubMed ID: 9250482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-MHV3 state induced by IFN gamma in macrophages is not related to arginine metabolism.
    Pereira CA; Soler G; Modolell M
    Arch Virol; 1997; 142(10):2001-10. PubMed ID: 9413508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
    Liu MF; Ning Q; Pope M; Mosmann T; Leibowitz J; Ding JW; Fung LS; Rotstein O; Gorczynski R; Levy GA
    Adv Exp Med Biol; 1998; 440():415-23. PubMed ID: 9782309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting hepatic macrophages to treat liver diseases.
    Tacke F
    J Hepatol; 2017 Jun; 66(6):1300-1312. PubMed ID: 28267621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.